| Item Type | Name |
|
Academic Article
|
Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group study.
|
|
Academic Article
|
Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Screening in ovarian cancer.
|
|
Academic Article
|
Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patients.
|
|
Academic Article
|
Preoperative serum tumor-associated antigen levels in women with pelvic masses.
|
|
Academic Article
|
New gynecologic cancer staging.
|
|
Academic Article
|
Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Chemoimmunotherapy in the management of primary stage III ovarian cancer: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study).
|
|
Academic Article
|
Prognostic factors in relation to second-look laparotomy in ovarian cancer.
|
|
Academic Article
|
Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies.
|
|
Academic Article
|
Assessment of the contemporary management of germ cell malignancies of the ovary.
|
|
Academic Article
|
Toxicity manifestations following intravenous Corynebacterium parvum administration to patients with ovarian and cervical carcinoma.
|
|
Academic Article
|
A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A Gynecologic Oncology Group Study.
|
|
Academic Article
|
Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: a Gynecologic Oncology Group Study.
|
|
Academic Article
|
Unreliability of urinary cytology in detecting gynecologic malignancy.
|
|
Academic Article
|
Carcinoma of the ovary associated with pregnancy.
|
|
Academic Article
|
The prognostic value of peritoneal cytology in gynecologic malignant disease.
|
|
Academic Article
|
A phase II study of PALA (NSC 224131) in patients with advanced ovarian carcinoma. A Gynecologic Oncology Group study.
|
|
Academic Article
|
Intracavitary Corynebacterium parvum for treatment of malignant effusions.
|
|
Academic Article
|
Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals.
|
|
Academic Article
|
Second-look laparotomy in ovarian cancer.
|
|
Academic Article
|
Ovarian cancer screening.
|
|
Academic Article
|
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
|
|
Academic Article
|
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience.
|
|
Academic Article
|
Tamoxifen in platinum-refractory ovarian cancer: a Gynecologic Oncology Group Ancillary Report.
|
|
Academic Article
|
Carcinoma of the ovary.
|
|
Academic Article
|
Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
|
|
Academic Article
|
Epithelial ovarian tumors of low malignant potential.
|
|
Academic Article
|
Hormone replacement therapy after cancers.
|
|
Academic Article
|
Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
|
|
Academic Article
|
A randomized trial of cyclophosphamide, doxorubicin, and cisplatin with or without bacillus Calmette-Guerin in patients with suboptimal stage III and IV ovarian cancer: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Surgical management of intestinal obstruction in ovarian cancer. I. Clinical features, postoperative complications, and survival.
|
|
Academic Article
|
Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells.
|
|
Academic Article
|
Phase II trial of VP-16-213 in the treatment of advanced squamous cell carcinoma of the cervix and adenocarcinoma of the ovary: a Gynecologic Oncology Group Study.
|
|
Academic Article
|
Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report).
|
|
Academic Article
|
Intestinal obstruction in patients with ovarian cancer. Variables associated with surgical complications and survival.
|
|
Academic Article
|
Retroperitoneal metastatic spread of ovarian cancer.
|
|
Academic Article
|
Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging.
|
|
Academic Article
|
Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding.
|
|
Academic Article
|
The role of adjuvant therapy in Stage I ovarian cancer.
|
|
Academic Article
|
A VP16-213- and cisplatin-containing regimen for treatment of refractory ovarian germ cell malignancies.
|
|
Academic Article
|
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group study.
|
|
Academic Article
|
Immune complexes in ovarian cancer.
|
|
Academic Article
|
Stage I borderline ovarian tumors.
|
|
Academic Article
|
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
|
|
Academic Article
|
Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
|
|
Concept
|
Ovarian Neoplasms
|
|
Academic Article
|
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
|